factors

Gain Therapeutics Achieves Remarkable Breakthrough in Parkinson’s Disease Research

Source Node:
Time Stamp: August 29, 2023 8:20 AM - Modified On: August 29, 2023 - Published By:
Source Cluster:
Republished By Plato

Gain Therapeutics, Inc. (Nasdaq: GANX), a pioneering biotechnology company specializing in innovative allosteric small molecule therapies, has made significant strides in the fight against Parkinson's disease (PD). The Company's lead drug candidate, GT-02287, has demonstrated extraordinary potential in mitigating the effects of Parkinson's disease across two distinct preclinical models of the ailment. These findings suggest that GT-02287 has the capacity to alleviate Parkinson's disease pathology and enhance motor function. A notable highlight is the substantial reduction of plasma Neurofilament Light Chain (NfL) levels, an emerging biomarker for neurodegeneration. This advancement

Livento Group, Inc. Announces Second Quarter Results with Revenue Growth of Over 90%, Including Significant Achievements and Updates

Source Node:
Time Stamp: August 17, 2023 3:06 PM - Modified On: August 17, 2023 - Published By:
Source Cluster:
Republished By Plato

NEW YORK, NY / August 14, 2023 / NuGene International, Inc./Livento Group, Inc. (OTC Pink:NUGN), a dynamic leader specializing in the acquisition and development of companies with disruptive business models in film, content, and technology sectors, is pleased to announce revenue growth of 91.65% for the second quarter of 2023, compared to the same period in 2022. Financial Highlights: Revenue Growth:The second quarter ending June 30, 2023, saw revenues of $431,184, up from $224,986 in 2022. For the six-month period ending June 30, 2023, revenues grew from $680,202 to $922,651, a growth of

GPOPPLUS (GPOX:US:OTC) Announces Impressive Revenue Results

Source Node:
Time Stamp: August 1, 2023 5:58 AM - Modified On: August 1, 2023 - Published By:
Source Cluster:
Republished By Plato

GPOPlus+, (GPOX:US:OTC) a leading provider and distributor of products for convenience stores and specialty retailers, gas stations, smoke shops, has recently announced an impressive surge in revenues during the fourth quarter of the year. The company reported a staggering 320% increase in its financial performance, marking a significant milestone for the organization. GPOPlus+ offers a unique technology driven direct store delivery model (“DSD”) that is creating both significant increases in revenue as well as improved unit economics with greater efficiencies yielding higher margins.  The Company has implemented this program successfully

Nutriband Inc. Launches AI Tape Brand Direct-to Consumer Offerings

Source Node:
Time Stamp: July 27, 2023 8:30 AM - Modified On: July 27, 2023 - Published By:
Source Cluster:
Republished By Plato

ORLANDO, FL / July 27, 2023 / Nutriband Inc. (the “Company”)(NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced the launch of its consumer sports recovery tape brand, Active Intelligence AI Tape (“AI Tape”), with products now available for purchase on Amazon and Activeintell.com. AI Tape is designed to combine many of the traditional benefits of kinesiology tape with the addition of soothing and therapeutic ingredients held in suspension with a proprietary adhesive mix. “We are very excited for the launch of our AI Tape brand, our first products targeting the consumer

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer’s Disease.

Source Node:
Time Stamp: June 7, 2023 12:22 PM - Modified On: June 7, 2023 - Published By:
Source Cluster:
Republished By Plato

Highlights Coya reports new data illustrating that administration of COYA 301 (low dose Interleukin-2 (IL-2)) in an open- label study in 8 patients with mild to moderate AD (COYA 301 Trial) resulted in a statistically significant reduction in the expression of three well characterized proinflammatory cytokines -- Tumor Necrosis Factor alpha (TNF-α), Interleukin 6 (IL-6), and Interleukin 1- Beta (IL-1β) -- which correlated with lack of cognitive decline of the patients over the course of the study. TNF-α is one of the main inflammatory cytokines involved in initiating and propagating

Paribus Vision

Source Node:
Time Stamp: May 27, 2023 11:55 AM - Modified On: May 27, 2023 - Published By:
Source Cluster:
Republished By Plato

For those who missed our announcements on social media, we are thrilled to share the exciting news that our Mainnet v1 will be relaunched on May 31st! The past few weeks have been demanding and challenging, but we couldn’t be happier with our progress. At Paribus, we have always emphasized the importance of security. While we were shocked and saddened by the exploitation of a loophole in our code, we firmly believe in finding the silver lining in every cloud. The steps we’ve taken following this unfortunate incident have made

Travelzoo META Opens for Founding Members

Source Node:
Time Stamp: May 11, 2023 7:21 AM - Modified On: May 11, 2023 - Published By:
Source Cluster:
Republished By Plato

NEW YORK/PARIS/TOKYO, May 11, 2023 - (ACN Newswire) - The future of travel is here. After months of anticipation, Travelzoo META, a members-only service offering groundbreaking Metaverse travel experiences, is now accepting its first one million Founding Members. Launched by Travelzoo® (NASDAQ: TZOO), a global Internet media company, Travelzoo META will give Founding Members the opportunity to be the first to experience travel in the Metaverse. Travelzoo META's experiences are intended to allow its members to explore hard-to-reach corners of the world, like summiting Mount Everest, or travel back in time—to

Paribus: A Regulatory Squeeze.

Source Node:
Time Stamp: February 15, 2023 3:26 AM - Modified On: February 15, 2023 - Published By:
Source Cluster:
Republished By Plato

A Regulatory Squeeze A common narrative you hear in crypto is that regulatory clarity will cause institutional investors to flood into the space. It’s often cited as the trigger for the next bull run. However, each time news of regulations hits the headlines markets plummet, and last week’s settlement between the SEC and Kraken was no exception. While it’s true that forward-thinking regulations will help to remove a lot of uncertainty from the space, it’s doubtful it will cause the next bull run. As we’ve seen from the present market

Paribus : Conflicting Narratives

Source Node:
Time Stamp: January 17, 2023 1:58 PM - Modified On: January 17, 2023 - Published By:
Source Cluster:
Republished By Plato

If the past year has taught us anything it’s that no one has a crystal ball when it comes to predicting future moves in the crypto market. Macroeconomic factors and black swan events have time and again overpowered technical analysis. This week China will celebrate the Lunar New Year and move from the year of the Tiger into the year of the Rabbit. Already there are several confusing and sometimes conflicting narratives as to what the coming year will bring. Many commentators are expecting 2023 to be beset by continued

Is the Future Digital?

Source Node:
Time Stamp: December 8, 2022 4:16 AM - Modified On: December 8, 2022 - Published By:
Source Cluster:
Republished By Plato

These days you can’t scroll through YouTube without encountering videos foretelling the end of crypto and the collapse of the global financial system. The clickbait culture that invaded traditional journalism has now spread to citizen journalism too, but how realistic are all of these dramatic claims? Fear, uncertainty, and doubt (FUD) pervade the mainstream media. So much so that even people with little knowledge of the technology claim it’s all going to zero. If you’re looking for bottom signals this is the equivalent of everyone FOMOing in at the top.